X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
male (54) 54
middle aged (50) 50
female (43) 43
cardiac & cardiovascular systems (38) 38
aged (29) 29
coronary angiography (26) 26
treatment outcome (23) 23
stent (22) 22
index medicus (20) 20
stents (20) 20
adult (18) 18
electrocardiography (16) 16
angioplasty, balloon, coronary (14) 14
cardiovascular (14) 14
follow-up studies (14) 14
thrombosis (14) 14
angioplasty (13) 13
prospective studies (13) 13
atherectomy, coronary (10) 10
cardiology (10) 10
coronary heart disease (10) 10
time factors (10) 10
analysis (9) 9
coronary vessels (9) 9
heart attacks (9) 9
lesions (9) 9
myocardial infarction (9) 9
abridged index medicus (8) 8
angiography (8) 8
care and treatment (8) 8
clopidogrel (8) 8
drug-eluting stents (8) 8
ischemia (8) 8
mechanisms (8) 8
percutaneous coronary intervention (8) 8
platelet aggregation inhibitors - therapeutic use (8) 8
transluminal angioplasty (8) 8
acute coronary syndromes (7) 7
angioplasty, balloon, coronary - adverse effects (7) 7
balloon angioplasty (7) 7
cardiac patients (7) 7
coronary artery disease - diagnostic imaging (7) 7
coronary artery disease - therapy (7) 7
disease (7) 7
hematology (7) 7
italy (7) 7
myocardial infarction - therapy (7) 7
recurrence (7) 7
risk factors (7) 7
angina (6) 6
cardiovascular disease (6) 6
internal medicine (6) 6
intervention (6) 6
medicine, general & internal (6) 6
peripheral vascular disease (6) 6
physiological aspects (6) 6
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (6) 6
primary angioplasty (6) 6
restenosis (6) 6
sirolimus - administration & dosage (6) 6
unstable angina (6) 6
angina pectoris - metabolism (5) 5
angina, unstable - therapy (5) 5
aspirin - therapeutic use (5) 5
atherosclerosis (5) 5
bleeding (5) 5
cardiology and cardiovascular medicine (5) 5
coronary artery disease - metabolism (5) 5
coronary artery disease - pathology (5) 5
coronary artery disease - surgery (5) 5
double-blind method (5) 5
exercise test (5) 5
immunosuppressive agents - administration & dosage (5) 5
implantation (5) 5
mortality (5) 5
myocardial infarction - etiology (5) 5
myocardial infarction - mortality (5) 5
platelet aggregation inhibitors - adverse effects (5) 5
radiography (5) 5
registry (5) 5
rotational atherectomy (5) 5
studies (5) 5
surgery (5) 5
ticlopidine - analogs & derivatives (5) 5
usage (5) 5
acute myocardial-infarction (4) 4
angina pectoris (4) 4
angina pectoris - etiology (4) 4
angina, unstable - drug therapy (4) 4
angina, unstable - metabolism (4) 4
angina, unstable - physiopathology (4) 4
angina, unstable - surgery (4) 4
artery (4) 4
artery disease (4) 4
aspirin (4) 4
cardiovascular system (4) 4
clinical trials (4) 4
complications (4) 4
coronary artery disease - complications (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1303 - 1313
This clinical trial compared two antiplatelet regimens during PCI: oral clopidogrel and intravenous cangrelor. As compared with clopidogrel, cangrelor resulted... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | METAANALYSIS | TICAGRELOR | CARDIOVASCULAR EVENTS | ACHIEVE OPTIMAL MANAGEMENT | CLOPIDOGREL PRETREATMENT | PRASUGREL | STANDARD THERAPY | ANTIPLATELET THERAPY | STRATEGIES | Double-Blind Method | Ticlopidine - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Adenosine Monophosphate - analogs & derivatives | Hemorrhage - etiology | Intention to Treat Analysis | Myocardial Ischemia - therapy | Ticlopidine - adverse effects | Female | Aged | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Stents - adverse effects | Thrombosis - mortality | Platelet Aggregation Inhibitors - adverse effects | Drugs | Dose-response relationship (Biochemistry) | Usage | Cangrelor | Angioplasty | Patient outcomes | Product/Service Evaluations | Hemorrhage | Risk factors | Control | Ischemia | Dosage and administration | Drug therapy | Myocardial infarction | Adenosine | Heart attacks | Intravenous administration | Thrombosis | Patients | Bleeding | Dyspnea | Implants | Clopidogrel | Acute coronary syndromes | Respiration
Journal Article
Journal Article
by Valgimigli, Marco and Frigoli, Enrico and Leonardi, Sergio and Vranckx, Pascal and Rothenbühler, Martina and Tebaldi, Matteo and Varbella, Ferdinando and Calabrò, Paolo and Garducci, Stefano and Rubartelli, Paolo and Briguori, Carlo and Andó, Giuseppe and Ferrario, Maurizio and Limbruno, Ugo and Garbo, Roberto and Sganzerla, Paolo and Russo, Filippo and Nazzaro, Marco and Lupi, Alessandro and Cortese, Bernardo and Ausiello, Arturo and Ierna, Salvatore and Esposito, Giovanni and Ferrante, Giuseppe and Santarelli, Andrea and Sardella, Gennaro and de Cesare, Nicoletta and Tosi, Paolo and van 't Hof, Arnoud and Omerovic, Elmir and Brugaletta, Salvatore and Windecker, Stephan and Heg, Dik and Jüni, Peter and Campo, Gianluca and Uguccioni, Lucia and Tamburino, Corrado and Presbitero, Patrizia and Zavalloni-Parenti, Dennis and Ferrari, Fabio and Ceravolo, Roberto and Tarantino, Fabio and Pasquetto, Giampaolo and Casu, Gavino and Mameli, Stefano and Stochino, Maria Letizia and Mazzarotto, Pietro and Cremonesi, Alberto and Saia, Francesco and Saccone, Giovanni and Abate, Fabio and Picchi, Andrea and Violini, Roberto and Colangelo, Salvatore and Boccuzzi, Giacomo and Guiducci, Vincenzo and Vigna, Carlo and Zingarelli, Antonio and Gagnor, Andrea and Zaro, Tiziana and Tresoldi, Simone and Vandoni, Pietro and Contarini, Marco and Liso, Armando and Dellavalle, Antonio and Curello, Salvatore and Mangiacapra, Fabio and Evola, Rosario and Palmieri, Cataldo and Falcone, Camillo and Liistro, Francesco and Creaco, Manuela and Colombo, Antonio and Chieffo, Alaide and Perkan, Andrea and De Servi, Stefano and Fischetti, Dionigi and Rigattieri, Stefano and Sciahbasi, Alessandro and Pucci, Edoardo and Romagnoli, Enrico and Moretti, Luciano and Moretti, Claudio and De Caterina, Raffaele and Caputo, Marcello and Zimmarino, Marco and Bramucci, Ezio and Di Lorenzo, Emilio and Turturo, Maurizio and Bonmassari, Roberto and Penzo, Carlo and Loi, Bruno and Mauro, Ciro and Petronio, Anna Sonia and Gabrielli, Gabriele and Micari, Antonio and Belloni, Flavia and Amico, Francesco and Comeglio, Marco and Fresco, Claudio and ... and MATRIX Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 835 - 848
The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the... 
2017 ESC | SITE | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 10/2013, Volume 6, Issue 10, pp. 1055 - 1063
Journal Article
by Andò, Giuseppe and Cortese, Bernardo and Russo, Filippo and Rothenbühler, Martina and Frigoli, Enrico and Gargiulo, Giuseppe and Briguori, Carlo and Vranckx, Pascal and Leonardi, Sergio and Guiducci, Vincenzo and Belloni, Flavia and Ferrari, Fabio and de la Torre Hernandez, Jose Maria and Curello, Salvatore and Liistro, Francesco and Perkan, Andrea and De Servi, Stefano and Casu, Gavino and Dellavalle, Antonio and Fischetti, Dionigi and Micari, Antonio and Loi, Bruno and Mangiacapra, Fabio and Russo, Nunzio and Tarantino, Fabio and Saia, Francesco and Heg, Dik and Windecker, Stephan and Jüni, Peter and Valgimigli, Marco and Salomone, Maria and Frigoli, Enrico and Occhilupo, Pierpaolo and Lodolini, Veronica and Monti, Monia and Mazzone, Maria Grazia and Delos, Erika and Caruso, Maria Teresa and Testa, Maggie and Ciociano, Nestor and Lazzero, Maurizio and Gazzotti, Davide and Cagliari, Lorenzo and Shahmohammadi, Leila and Caiazza, Martina and Virga, Vittorio and Guerra, Elena and Michalska, Eva and Castellini, Sara and Serino, Vincenzo and Visconti, Gabriella and Pendenza, Gianluca and Portolan, Monica and Anzini, Marco and Silvetti, Elisa and Coco, Tiziana and Costa, Francesco and Ariotti, Sara and Valli, Linda and Adamo, Marianna and Marino, Marcello and Vranckx, Pascal and Leonardi, Sergio and Tricoci, Pierluigi and Jüni, Peter and Rothenbühler, Martina and Heg, Dik and Valgimigli, Marco and Gagnor, Andrea and Calabrò, Paolo and Rubartelli, Paolo and Garducci, Stefano and Santarelli, Andrea and Galli, Mario and Garbo, Roberto and Bramucci, Ezio and Ierna, Salvatore and Briguori, Carlo and Cortese, Bernardo and Limbruno, Ugo and Violini, Roberto and Presbitero, Patrizia and de Cesare, Nicoletta and Sganzerla, Paolo and Ausiello, Arturo and Tosi, Paolo and Sardella, Gennaro and Sabate, Manel and Brugaletta, Salvatore and Saccone, Giovanni and Vandoni, Pietro and Zingarelli, Antonio and Liso, Armando and Rigattieri, Stefano and Di Lorenzo, Emilio and Vigna, Carlo and Palmieri, Cataldo and Falcone, Camillo and De Caterina, Raffaele and Caputo, Marcello and ... and MATRIX Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2017, Volume 69, Issue 21, pp. 2592 - 2603
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2011, Volume 4, Issue 1, pp. 14 - 23
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article